Medikamentenfreisetzende Stents
Today’s PCI standard — compare drug, polymer and strut thickness.
XIENCE Skypoint
Everolimus stent with a fluoropolymer and one of the largest clinical evidence bases.
Wirkstoff: Everolimus
SYNERGY XD / MEGATRON
Everolimus stent with abluminal bioabsorbable polymer; MEGATRON for large vessels and left main.
Wirkstoff: Everolimus
Onyx Frontier
Zotarolimus stent with Pt-Ir core for visibility; 2.0 mm size for small vessels.
Wirkstoff: Zotarolimus
Orsiro Mission
Ultrathin (60 µm) sirolimus stent with biodegradable polymer.
Wirkstoff: Sirolimus
Ultimaster Tansei
Sirolimus stent with abluminal gradient bioresorbable coating.
Wirkstoff: Sirolimus
Firehawk Liberty
Low-dose sirolimus stent with drug in recessed abluminal grooves.
Wirkstoff: Sirolimus (low dose, recessed abluminal grooves)
BioMime
Thin-strut sirolimus stent with hybrid cell design.
Wirkstoff: Sirolimus
Supraflex Cruz
Ultrathin-strut sirolimus stent.
Wirkstoff: Sirolimus
BioFreedom Ultra
Polymer-free stent studied in high-bleeding-risk patients with short dual antiplatelet therapy.
Wirkstoff: Biolimus A9
Cre8 EVO
Italian polymer-free stent with abluminal drug reservoirs; studied in diabetic patients.
Wirkstoff: Amphilimus (sirolimus + fatty acid)